[1]
S. Günaydın, H. Bektaş Aksoy, İskender Aksoy, A. Elmas, and A. C. Dülger, “Factors Affecting Mortality in COVID-19 Pneumonia Patients Treated with Tocilizumab”, Eur Res J, vol. 12, no. 7, pp. 780–788, May 2026, doi: 10.18621/eurj.1829791.